Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Susquehanna Reiterates Neutral on NOW, Maintains $14 Price Target

Susquehanna Reiterates Neutral on NOW, Maintains $14 Price Target

Susquehanna analyst Charles Minervino reiterates NOW (NYSE:DNOW) with a Neutral and maintains $14 price target.

byBenzinga Newsdesk

March 14, 2023

1 minute read

Susquehanna analyst Charles Minervino reiterates NOW (NYSE:DNOW) with a Neutral and maintains $14 price target.

Baker Hughes, Woodside Energy To Collaborate On Decarbonizing Natural Gas Supply Chain

By Benzinga Newsdesk

December 8, 10:17 AM

https://www.bakerhughes.com/company/news/baker-hughes-and-woodside-energy-collaborate-decarbonizing-natural-gas-supply-chain

BKR

News

VBI Vaccines Announces PreHevbri Is Now Available In The Netherlands And Belgium For The Prevention Of Hepatitis B In Adults

By Benzinga Newsdesk

July 19, 8:14 AM

PreHevbri® is the only approved 3-antigen hepatitis B vaccine for adults in the Netherlands and BelgiumProduct to be launched via marketing and distribution partner, ValnevaVBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a

VBIV

Mizuho Maintains Neutral on Livent, Lowers Price Target to $30

By Benzinga Newsdesk

August 4, 11:03 AM

Mizuho analyst Christopher Parkinson maintains Livent (NYSE:LTHM) with a Neutral and lowers the price target from $34 to $30.

LTHM

Chicago Cannabis Company Green Thumb Proposes Merger With Boston Beer, Eyes Stock Listing

By Patricio Liddle

June 4, 4:11 PM

Green Thumb writes a letter to Boston Beer seeking a merger to gain access to NYSE and develop innovative cannabis-infused products. Read now!

BUD

Susquehanna Reiterates Neutral on NOW, Maintains $14 Price Target

Related Posts

Baker Hughes, Woodside Energy To Collaborate On Decarbonizing Natural Gas Supply Chain

VBI Vaccines Announces PreHevbri Is Now Available In The Netherlands And Belgium For The Prevention Of Hepatitis B In Adults

Mizuho Maintains Neutral on Livent, Lowers Price Target to $30

Chicago Cannabis Company Green Thumb Proposes Merger With Boston Beer, Eyes Stock Listing